Alvotech (ALVO) Cash & Equivalents (2020 - 2025)

Alvotech has reported Cash & Equivalents for 6 years, with the latest figure at $172.4 million in Q4 2025.

• For the quarter ending Q4 2025, Cash & Equivalents rose 235.15% year-over-year to $172.4 million; the trailing twelve-month figure through Dec 2025 stood at $172.4 million (up 235.15% YoY), and the FY2025 full-year result was $172.4 million, up 235.15% from the prior year.
• Cash & Equivalents for Q4 2025 stood at $172.4 million, up from $51428.0 in the prior quarter.
• The five-year high for Cash & Equivalents was $172.4 million in Q4 2025, with the low at $51428.0 in Q3 2025.
• Historically, Cash & Equivalents has averaged $57.8 million across 5 years, with a median of $51.4 million in 2024.
• The largest YoY upside for Cash & Equivalents was 369.92% in 2025 against a maximum downside of 99.96% in 2025.
• Alvotech's Cash & Equivalents stood at $17.6 million in 2021, then soared by 278.37% to $66.4 million in 2022, then slumped by 83.2% to $11.2 million in 2023, then surged by 360.95% to $51.4 million in 2024, then soared by 235.15% to $172.4 million in 2025.
• The last three Cash & Equivalents figures came in at $172.4 million (Q4 2025), $51428.0 (Q3 2025), and $51.4 million (Q2 2025), per Business Quant data.